Clinical Takeaway Clinical evidence for cannabinoids in treating mental disorders and substance use disorders remains limited, with most approved uses not yet supported by rigorous randomized controlled trial data. Current research does...
`Cannabinoid Clinical Trials for Mental & Substance Disorders`
Clinical Takeaway Systematic review and meta-analysis of randomized controlled trials found limited evidence supporting cannabinoids as a primary treatment for mental disorders or substance use disorders. Current data do not establish clear...